Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
42 studies found for:    Open Studies | "Organ Transplantation"
Show Display Options
Rank Status Study
21 Recruiting Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients
Condition: Immunosuppression
Intervention: Other: Blood Sample
22 Recruiting Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients
Condition: Nonmelanoma Skin Cancers
Intervention: Other: have Levulan Kerastick (aminolevulinic acid) solution
23 Not yet recruiting Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
Conditions: Post-transplant Lymphoproliferative Disease;   Transplant-Related Hematologic Malignancy
Interventions: Biological: Autologous EBV-CTL transduced with vector SFG-CNA12;   Biological: Autologous EBV-CTL transduced with control vector SFG-CNA8;   Procedure: Leucapheresis
24 Recruiting Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)
Conditions: Cardiovascular Disease;   Acute Rejection of Cardiac Transplant;   Cardiac Transplant Rejection;   Heart Transplant Failure and Rejection
Intervention: Diagnostic Test: Blood Draw of up to 10 ml
25 Recruiting Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
Condition: Gram Negative Infection
Intervention:
26 Recruiting Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate gel 0.015%
27 Recruiting Transplanting Hepatitis C Positive Thoracic Organs
Conditions: Hepatitis C;   Awaiting Organ Transplant
Interventions: Drug: Sofosbuvir/velpatasvir;   Other: Monitoring
28 Recruiting HIV-to-HIV Transplant at MGH
Conditions: HIV;   Awaiting Organ Transplant
Intervention:
29 Recruiting Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
Conditions: Validation Study of Molecular Diagnostic System;   Development of Reporting System for Molecular Diagnosis;   Incorporate Molecular Diagnosis Into Diagnostic Standards
Intervention:
30 Recruiting The ONE Study M Reg Trial
Condition: Renal Failure, End Stage
Intervention: Biological: Donor M reg (Mreg_UKR)
31 Recruiting Transplantoux Health Evaluation Study
Condition: Quality of Life
Interventions: Other: Home-based indiviualized exercise training program;   Other: Supervised group training sessions;   Other: Climb of the Mont Ventoux
32 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine
33 Recruiting Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL
Conditions: Invasive Fungal Infection;   Hematological Malignancy;   Receipt of Solid Organ Transplant
Intervention: Other: Fungitell Assay in BAL
34 Recruiting Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft Versus Host Disease;   Chronic GVHD;   Complications of Organ Transplant Stem Cells
Interventions: Other: Treg-enriched infusion;   Drug: Interleukin-2
35 Recruiting Cell-mediated Immunity for Prevention of CMV Disease
Condition: Cytomegalovirus Infections
Intervention: Other: T-Track® CMV assay
36 Recruiting Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive Cluster of Differentiation(CD) 20-Positive Post-Transplant Lymphoproliferative Disorder
Conditions: Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder;   Monomorphic Post-Transplant Lymphoproliferative Disorder;   Polymorphic Post-Transplant Lymphoproliferative Disorder
Interventions: Biological: Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes;   Other: Laboratory Biomarker Analysis;   Biological: Rituximab
37 Recruiting Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy
Condition: Posttransplant Lymphoproliferative Disorder
Interventions: Drug: Rituximab sc;   Drug: Rituximab sc consolidation;   Drug: Rituximab sc combined with CHOP chemotherapy;   Drug: Rituximab sc combined with alternating chemotherapy with CHOP and DHAOx
38 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
39 Recruiting New Generation IGRA in Immunocompromised Individuals
Conditions: Monitoring, Immunologic;   Active Tuberculosis;   Tuberculosis in Solid Organ Transplant Recipients;   Tuberculosis in Marrow Transplant Recipients;   Tuberculosis in Rheumatoid Arthritis;   Tuberculosis in Chronic Renal Failure;   Tuberculosis in HIV-infected Individuals
Intervention:
40 Recruiting University of Minnesota Transplant Registry
Conditions: Transplant Recipient;   Transplant Donation
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.